The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus (Q38095861)

28 August 2017

The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus (English)

1 reference

28 August 2017

1 reference

J L Scholz

1

1 reference

28 August 2017

M A Oropallo

2

1 reference

28 August 2017

V Sindhava

3

1 reference

28 August 2017

R Goenka

4

1 reference

28 August 2017

M P Cancro

5

1 reference

28 August 2017

1 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

22

1 reference

28 August 2017

4

1 reference

28 August 2017

350-360

1 reference

Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients

28 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Targeting BAFF in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Space, selection, and surveillance: setting boundaries with BLyS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF inhibition: a new class of drugs for the treatment of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Regulation of autoreactive antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B-cell self-tolerance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The role of B cells in lupus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Mechanisms of B cell autoimmunity in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B-cell tolerance checkpoints in health and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

21 January 2018

Cracking the BAFF code.

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Beyond transitional selection: New roles for BLyS in peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF, APRIL and their receptors: structure, function and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Homeostatic control of B lymphocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The BLyS family: toward a molecular understanding of B cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BCMA is essential for the survival of long-lived bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF, APRIL and human B cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Alternative mechanisms of receptor editing in autoreactive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Receptor editing for better or for worse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Central B-cell tolerance: where selection begins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The turnover of B-cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The scope of receptor editing and its association with autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Perspectives on the nature of BCR-mediated survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Fate decisions regulating bone marrow and peripheral B lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Positive and negative selection during B lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF and the plasticity of peripheral B cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Signalling crosstalk in B cells: managing worth and need

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Novel human transitional B cell populations revealed by B cell depletion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Defective B cell tolerance checkpoints in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Persistent expression of autoantibodies in SLE patients in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Manipulating B cell homeostasis: a key component in the advancement of targeted strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Affinity-based selection and the germinal center response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The immortality of humoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Germinal center selection and the development of memory B and plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Death-receptor contribution to the germinal-center reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Impaired IgA class switching in APRIL-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Regulated expression of BAFF-binding receptors during human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

APRIL-deficient mice have normal immune system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Intrinsic properties of human and murine memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

IgM memory B cells: a mouse/human paradox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Memory B cells: effectors of long-lived immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Exploiting human memory B cell heterogeneity for improved vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoreactivity in human IgG+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B cell therapies for rheumatoid arthritis: beyond B cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Lupus: novel therapies in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Toll-like receptors in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Modulation of B cell responses by Toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

T-independent type II immune responses generate memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

B cell receptor editing in tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469453

21 January 2018

Identifiers

DOI

10.1177/0961203312469453

1 reference

28 August 2017

1 reference